Mittleman Brothers Increased Revlon (REV) Holding By $16.70 Million; Universal Health Services (UHS) Sentiment Is 0.9

February 11, 2018 - By Peter Erickson

Mittleman Brothers Llc increased Revlon Inc (REV) stake by 30.2% reported in 2017Q3 SEC filing. Mittleman Brothers Llc acquired 695,966 shares as Revlon Inc (REV)’s stock declined 45.08%. The Mittleman Brothers Llc holds 3.00 million shares with $73.66 million value, up from 2.30 million last quarter. Revlon Inc now has $1.07B valuation. The stock increased 2.00% or $0.4 during the last trading session, reaching $20.4. About 102,024 shares traded or 25.29% up from the average. Revlon, Inc. (NYSE:REV) has declined 37.40% since February 11, 2017 and is downtrending. It has underperformed by 54.10% the S&P500.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health facilities, and ambulatory centers. The company has market cap of $10.94 billion. The companyÂ’s hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. It has a 15.84 P/E ratio. As of February 28, 2017, it owned and/or operated 26 inpatient acute care hospitals, 4 free-standing emergency departments, 1 surgical hospital, and 319 inpatient and 33 outpatient behavioral health care facilities located in 37 states, Washington, D.C.; the United Kingdom; Puerto Rico; and the U.S.

Westport Asset Management Inc holds 8.72% of its portfolio in Universal Health Services, Inc. for 119,661 shares. Maverick Capital Ltd owns 5.86 million shares or 8.25% of their US portfolio. Moreover, Jana Partners Llc has 4.36% invested in the company for 1.89 million shares. The Massachusetts-based Sirios Capital Management L P has invested 3% in the stock. New Mountain Vantage Advisers L.L.C., a New York-based fund reported 291,914 shares.

Analysts await Universal Health Services, Inc. (NYSE:UHS) to report earnings on February, 27. They expect $1.84 EPS, up 2.22% or $0.04 from last year’s $1.8 per share. UHS’s profit will be $174.60M for 15.66 P/E if the $1.84 EPS becomes a reality. After $1.64 actual EPS reported by Universal Health Services, Inc. for the previous quarter, Wall Street now forecasts 12.20% EPS growth.

The stock increased 0.36% or $0.41 during the last trading session, reaching $115.28. About 917,580 shares traded. Universal Health Services, Inc. (UHS) has declined 11.23% since February 11, 2017 and is downtrending. It has underperformed by 27.93% the S&P500.

Investors sentiment decreased to 1.08 in 2017 Q3. Its down 0.39, from 1.47 in 2017Q2. It dropped, as 17 investors sold REV shares while 19 reduced holdings. 18 funds opened positions while 21 raised stakes. 7.76 million shares or 6.02% more from 7.32 million shares in 2017Q2 were reported. 1,798 were accumulated by Bnp Paribas Arbitrage Sa. The Washington-based Parametric Portfolio Associate Ltd Company has invested 0% in Revlon, Inc. (NYSE:REV). Smithfield Trust invested in 370 shares. Invesco Ltd holds 0% or 16,236 shares in its portfolio. Amundi Pioneer Asset Mgmt Incorporated invested in 42,664 shares. Wells Fargo Mn invested in 16,582 shares or 0% of the stock. Oz Limited Partnership stated it has 0% of its portfolio in Revlon, Inc. (NYSE:REV). Citadel Advsrs Ltd Company holds 125,830 shares or 0% of its portfolio. Northern Tru Corp reported 157,484 shares stake. 14,400 were accumulated by New York State Common Retirement Fund. Carroll Financial Assoc invested in 0% or 587 shares. Alliancebernstein Lp invested 0% in Revlon, Inc. (NYSE:REV). Peak6 Investments Ltd Partnership reported 30,667 shares. California Employees Retirement System invested in 87,333 shares. Aperio Grp Limited Co holds 0% or 8,698 shares.

Since September 19, 2017, it had 2 insider buys, and 0 selling transactions for $13.05 million activity. $2.20M worth of Revlon, Inc. (NYSE:REV) shares were bought by PERELMAN RONALD O.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: